Autism spectrum disorder (ASD) is a neurodegenerative disorder affecting the quality of life of a significant number of children and adults around the world. Despite its growing epidemiology, the causes of autism are still not known. Research has linked the disorder with brain pathology, with a possible prenatal onset. It has been reported that the brain area involved in autism is the cerebellum, and more specifically, a disruption within Purkinje cells. For this reason, Purkinje cells are among the most studied brain cells in relation to ASD. Despite the amount of research on the topic and different techniques applied, the aetiology of ASD is still unclear. One of the possible causes of the relationship between ASD and Purkinje cell abnormality might be their vulnerability. Studies suggest that Purkinje cell loss might occur early in life (in the prenatal or neonatal period) as a result of contact with toxins or brain damage. The aim of this review is to describe the most important findings in the field and discuss the aetiological connection between Purkinje cell loss and ASD. First, this review discusses the neurological basis of autism. Then, the evidence of the link between Purkinje cell damage and ASD, presented in such studies, is described. The main part of the article analyses major studies within the field. They have been grouped based on the research techniques applied: mutant mice models, histopathological examinations, and in vivo neuroimaging. At the end, the limitations of the study and future research possibilities are discussed.
Introduction
Autism spectrum disorder (ASD) is a pervasive developmental disorder characterised by social, linguistic, and sensorimotor deficits (McPartland et al. 2012) . Because the number of children diagnosed with ASD has significantly grown in recent years, researchers seek the cause of ASD. For instance, in 1984 in the USA, only four in 10,000 children were diagnosed with autism (Ritvo et al. 1986 ), but the prevalence rose to six per 10,000 in 1994, and 31 per 10,000 in 2003 (Shattuck 2006) . There is consistent research trying to find a neurological basis for autism. ASD has been linked to the impairment of several brain areas such as hypoactivation of the inferior frontal gyrus (Dapretto et al. 2006) , cortical thinning (Hardan et al. 2006 ; Wallace et al. 2010) , enlarged amygdala (Munson et al. 2006) , and transverse relaxation of grey matter (Petropoulos et al. 2006) . Previous studies on autism have also found a connection between cerebellar dysfunction in people with ASD and a loss of Purkinje cell volume (Fatemi et al. 2002) . Over the last two decades, a number of studies have proven this relationship in brains of many autistic patients (Ritvo et al. 1986; Bailey et al. 1998; Fatemi et al. 2002) .
According to Galen, the cerebellum was first mentioned by Aristotle and Herophilus. However, Galen's research was the earliest account on the cerebellum, and he was the first to link the cerebellum with motor functions (Finger 2001 ). In the 16 th Century, Leonardo da Vinci researched brain structure and named one part of the brain the "cerebellum" (Gross 1997 ). The name given by da Vinci to the cerebellum evoked its small size. In fact, despite the cerebellum comprising only 10% of brain volume, it contains around half of the brain's neurons (Li et al. 2013 ). The cerebellum is composed of Kamil D. Lucci only six main types of cells (granule, purkinje, golgi, unipolar brush, basket, and stellate). Its organisation is very regular, processing similar signals in the same way (Voogd and Glickstein 1998) . However, the exact role of the cerebellum is still being researched. Initially, it was believed that the role of the cerebellum was primarily balance and motor control, while the cerebral cortex was responsible for cognitive functions (Schmahmann and Sherman 1998) . However, evidence suggests that the cause of the severity of malfunctions related to the cerebellum might lie with it receiving input from areas crucial for the body's functioning: the vestibular nerve (responsible for sensory input), the spinal cord (affecting muscle tone and crude movements), the pontine nuclei (regulating the cerebral cortical output), and the cerebral cortex (learning and regulating behaviours; Voogd and Glickstein 1998).
Despite the cerebellum being known at least since Late Antiquity, the discovery of Purkinje cells was only made in the mid -19 th Century by Johannes Purkinje. This finding was crucial for today's understanding of the cerebellum. Purkinje cells were first noticed for their large size, and later research reported the crucial role they play in the functioning of the brain. Purkinje cells are situated in the middle layer of the cerebellar cortex, between the outer molecular and the inner granular layer. They send inhibitory projections to the deep cerebellar nuclei, and some Purkinje cells send axons directly to the vestibular nuclei located in the brainstem (Stoodley 2012) . Further studies on those neurons have associated their role with delivering information from the cerebellum to the cerebral cortex (Schmahmann and Sherman 1998) . They are said to both receive information from the outer layer of the cerebellum and send signals to the deep cerebellar nuclei in the centre of the cerebellum. Research on the role of the cerebellum and its Purkinje cells has helped increase the understanding of disorders such as Alzheimer's (Joachim et al. 1989 ) and autism (Fatemi et al. 2002) . Because their malfunctioning affects functions known to play a role in ASD, researchers claim that Purkinje cells are closely linked to the aetiology of autism (Bailey et al. 1998) . Despite the fact that this topic has been studied for over two decades, researchers met for the first time at the 2015 Society of Neuroscience conference to present and discuss the involvement of Purkinje cells in ASD (Role 2015) .
Overall, a large number of studies have found loss of these cells in a large percentage of autism cases, especially those without a clear genetic aetiology (Ritvo et al. 1986; Fatemi et al. 2002) . Because the aetiology of ASD is still not known, researchers search for an explanation that would enhance the treatment and prevention of ASD. Over the years, various techniques have been implemented in research on Purkinje cells and autism -studies using modified animals, post-mortem studies, and in vivo studies implementing the latest scanning methods. It is crucial to analyse the results of each of those perspectives.
Cerebellum impairment and its link to autism
Despite the fact that some studies are reporting an increase of cerebellar volume in autistic patients (Traut et al. 2018 ), most studies conclude that volume loss in the cerebellum is positively correlated with autism (Ritvo et al. 1986; Bailey et al. 1998; Fatemi et al. 2002) . For instance, Courchesne et al. (1993) found that the posterior lobe (lobules VI and VII) and the vermis (lobules VIII-X) in the cerebellum were significantly smaller in autistic subjects.
However, Fatemi et al. (2002) reported in their study no changes in Purkinje cell density in autistic patients and only a decreased size of the Purkinje cell somata. In other studies, it was found that Purkinje cell numbers were significantly decreased (Ritvo et al. 1986; Bailey et al. 1998) . Because autism exhibits a very broad range of severity, it is possible that Purkinje cell loss is only evident in the most severe cases.
Neurological basis of autism
An important number of post-mortem studies have reported cerebellar pathology in autistic brains (Ritvo et al. 1986; Bailey et al. 1998) . Imaging studies have also reported increased cerebellar Purkinje cell volume loss in ASD patients (Ritvo et al. 1986; Fatemi et al. 2002) .
In the past the only behaviours linked to the cerebellum were motor coordination and motor learning (Schmahmann and Sherman 1998) . Thanks to the development of research on Purkinje cells, it is now believed that the cerebellum is not only a regulator of movement, but also the brain region responsible for cognitive functions such as language, visual and spatial understanding, auditory processing, verbal memory, fine motor regulation, and executive function (Hampson and 
Purkinje cell impairment in the cerebellum
As mentioned above, the loss of Purkinje cells negatively influences the functioning of the frontal cortex. A study by Beversdorf et al. (2005) linked an early manifested ASD symptoms in children who born prematurely with a reported cerebellar injury. The role of Purkinje cells in the brain is closely related to the effect of their loss on human (and animal) behaviour (Sudarov 2013 ). Purkinje cells are reported to receive excitatory input from cerebellar granule cells, and in turn, using gamma-aminobutyric acid (GABA) as a neurotransmitter, provide inhibition to the deep cerebellar nuclei (Sudarov 2013) . Then, the four deep nuclei send projections to brain areas vital for our functioning, such as the thalamus, and through it to the cerebral cortex (Sudarov 2013 ). This might influence the functioning of several mechanisms within the brain. For instance, Purkinje cell disruption might affect cerebellar modulation of dopamine release in the prefrontal cortex (Sudarov 2013 ). Then, it is possible that Purkinje cell pathology leads to an imbalance of the excitation and inhibition processes in the cortex (Sudarov 2013) . It has been hypothesised that this may be one of the mechanisms causing ASD because the abnormally functioning cortex is responsible for memory, perception, cognition, and motor control ( However, it has also been hypothesised that the cause of Purkinje cell loss is their vulnerability. The effect of neonatal exposure to heavy metals and toxins on diminishing Purkinje cell numbers is widely discussed in the literature (Sowell et al. 1996 
Autopsy studies on brains of autistic individuals
Decreased Purkinje cell density and/or number of Purkinje cells is a relatively consistent observation across post-mortem studies. Despite their importance, studies on the brains of deceased individuals tend to have very small sample sizes. For instance, Ritvo et al.'s (1986) paper presents one of the earliest studies seeking to determine the number of Purkinje cells in autistic brains. They examined the brains of only four 10-22-year-old autistic males and compared them with three 3-23-year-old male and one five-year-old female control/s. Despite their successful link between autism and decreased numbers of Purkinje cells, their findings would be more reliable if a larger sample size were used. Unfortunately, despite the fact that over 30 years have passed since Ritvo et al.'s (1986) study, no research has used a significant number of brains in their studies. Thus, the generalisability of their findings might be questioned.
Although Kemper and Bauman's (1993) article is one of the earliest studies on Purkinje cells in autistic brains, it is one of the most comprehensive studies using the autopsy technique. In the study, examination was performed Kamil D. Lucci of six brains of autistic patients in their 20s and 30s. All six cases were compared with controls of identical age and same sex proportions. The findings revealed pathologies in both the cerebellum and forebrain. However, Kemper and Bauman (1993) focused their research only on the cerebellar area. Similarly to other studies discussed in this article, the researchers found a significant decrease of Purkinje cell density in all tested brains. However, the density loss varied from 50% to 95%. Interestingly, despite severe abnormalities in Purkinje cells, the cerebellar cortex was developed in all tested brains.
Kemper and Bauman (1993) hypothesised that in individuals who displayed typical infantile autism the cerebellar pathology might have its origins in the foetal stage. As predicted, the tested individuals seemed to have acquired the cerebellar lesions before being born. According to the authors, the cerebellar abnormalities appeared before the foetus entered its 30 th week of pregnancy. This finding suggests that ASD diagnosis might be made straight after birth. Because the changes in Purkinje cell structure was present in all studied cases, Kemper and Bauman (1993) concluded that ASD brains might be affected by cerebellar hypoplasia, a disorder of cerebellar maldevelopment.
Another early study reported similar findings to those obtained by Kemper and Bauman (1993). Bailey et al.'s (1998) study used post-mortem brain tissue obtained from six individuals with autism. It was discovered that not only Purkinje cell numbers were significantly reduced in all studied cases, but also that they presented more or less severe structural damage. The reduced number of Purkinje cells appeared all over the cerebellum area, their position was not regular, and the cell density was much lower than in healthy controls. However, Bailey et al. (1998) 
Purkinje cells in autistic mutant mice
The role of the cerebellum in autism remains a widely-researched topic, mainly because the link between abnormalities in social interactions and repetitive behaviours is still being investigated. Progress made in genetics in the last decade has provided the necessary tools to manipulate genes in animals and thus study complex neurological disorders. Using such techniques, Tsai et al. (2012) established a link between abnormal cerebellar Purkinje cell functioning and behavioural deficits that are relevant to ASD.
Recent animal studies have linked the Purkinje cell loss in the cerebellum to ASD, showing that not only humans are affected by their malfunctioning. However, the link between cerebellar dysfunction and ASD remains unclear; an important discovery was linking Purkinje cell loss to brain injuries. This opened the possibility Purkinje cells and autism spectrum disorder. Is there an aetiological connection? of investigating the pathology on animal models. Tsai et al. (2012) in their research used a combination of several methods (mouse mutations, electrophysiology, behavioural tests, and pharmacological manipulations) to investigate the role of tuberous sclerosis (TSC) in Purkinje cell dysfunction in the cerebellum. Tuberous sclerosis complex is a genetic disorder with high comorbidity with the ASD. The link between TSC and autism is caused by mutations in either TSC1 or TSC2, whose protein regulates the mechanistic target of rapamycin (mTOR) signalling (inhibition of which leads to the development of TSC). TSC causes brain tissue malformations leading to a number of neurological symptoms such as intellectual disability, behavioural problems, developmental delays, and epilepsy. Studies have shown that more than half of TSC patients develop ASD. Despite the knowledge of the TSC gene, the aetiological connection between these two disorders is still not known. Tsai et al. (2012) demonstrated that defects in Purkinje cell structure are positively correlated with autism. They discovered that mice with a TSC1 loss in their Purkinje cells exhibited behaviours similar to those encountered in ASD patients, including abnormal social interaction, repetitive behaviour, and vocalisations. Furthermore, they were reported to have a decreased Purkinje cell excitability. Interestingly, treatment with rapamycin (a mTOR inhibitor) prevented mice from showing any ASD-like behaviours. These findings demonstrate that there is a direct link between cerebellar disruption and cognitive disorders such as ASD. Reith et al. (2013) performed a similar study to the one presented above. Despite using mice with an induced TSC disorder, their new TSC mutant mouse model was designed to display a specific Purkinje cell TSC2 loss. In the TSC2 mutant mice Purkinje cell degeneration developed during the course of the study. This study is the first one to show a connection between Purkinje cell degeneration and loss of PTEN, and autistic spectrum disorder. Those findings add to earlier studies by Tsai et al. (2012) and Reith et al. (2013) .
Despite being performed on mice, these animal model studies might make an important contribution to the future treatment of ASD.
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The importance of those studies lies not only in demonstrating the link between the causes of ASD and neurodegeneration, but also it sheds light into new methods of treatment of ASD. For instance, rapamycin used in Reith et al.'s (2013) study is an immunosuppressant widely researched for treating disorders such as TSC and ASD. Despite its known side effects, rapamycin treatment trials are seeking to develop a new drug for both disorders.
In vivo studies: neuroimaging and parental reports
Contrary to autopsy studies, neuroimaging allows a greater number of individuals to be tested. Unfortunately, in vivo studies involving brain scanning methods are not very well represented in the topic of Purkinje cell loss. Despite the small number of imaging studies, they confirm the results obtained in animal model and autopsy studies.
One of the earliest studies involving neuroimaging of autistic patients is presented in Courchesne et al.'s (1993) research. Their study used MR images of a sample of 21 healthy autistic patients and MR scans of control subjects without any neuroanatomic abnormalities. The age of all tested individuals varied between 5 and 35 years of age. The study reported reduced volume loss in in several brain areas (parietal, superior frontal and occipital lobes, and the corpus callosum). Despite the fact that this early study did not involve the cerebellum, it hypothesised that similar findings might be obtained in that brain area. Furthermore, Courchesne et al.'s (1993) study linked the above-listed cerebral abnormalities with Purkinje neuron loss that, according to them, would have a very early onset (probably in the gestational period), but the first symptoms might be detected only later in life. Furthermore, Courchesne et al. (1993) hypothesised that both genetic and non-genetic causes underlying Purkinje neuron pathologies disrupt neuronal growth in other brain areas.
A more recent study presented by Jeong et al. (2014) focused on the connection between Purkinje cell loss and ASD. However, previous research has been conducted on the same topic by the same team; the most recent study (Jeong et al. 2014 ) sums up well the previous findings. In their latest study, Jeong et al. (2014) used a diffusion-weighted MRI tractography on 15 autistic children and 14 healthy controls. The aim of their research was to investigate whether it is possible to detect any structural abnormalities in Purkinje cells in living ASD patients. The diffusion-weighted MRI tractography was calibrated to detect any abnormalities in those cerebellar areas that previous post-mortem studies have identified as most at risk of being affected by Purkinje cells loss. Using this method, Jeong et al. (2014) found a reduced number and volume of Purkinje cells across the cerebellum in children with ASD diagnoses compared to their healthy peers. Furthermore, Jeong et al. (2014) findings are very similar to those described in post-mortem studies. This method, however innovative and not without its limitations, confirm that neuroimaging techniques can be used in substitution for older, post-mortem brain studies. There is hope that these new techniques might shed new light on Purkinje cell research.
A small number of studies have sought to investigate the link between neurodegeneration and early onset ASD through parental reports (using questionnaires). For instance, Kern et al. (2002) report that over 80% of the surveyed parents reported postnatal abnormalities in their children. Those pathologies were supposed to appear before the child received an ASD diagnosis. However, they claimed that most parents noticed early developmental delays in their children, and the results were highly unreliable due to the method used. Despite being non-invasive this research method seemed not to be appropriate. The limited number of studies on Purkinje cells and autism might be caused by the expensive methods used and the expertise needed to perform them (mutant animal models, pathological examinations, neuroimaging). Despite the existence of some parental report studies on Purkinje cells and autism (Kern et al. 2002) , the efficacy and reliability is questionable. Firstly, Purkinje cells and autism spectrum disorder. Is there an aetiological connection? the developmental abnormalities reported in children after birth are hardly linked with neurodegeneration of a particular brain area (Kern et al. 2002) . Secondly, as shown in several other studies based on parental reports, parents might be oversensitive to their child's abnormal development (Glascoe 1994) , and the study design might affect their responses (Kroes et al. 2003) .
Limitations and possibilities of future development
The major weakness of research on Purkinje cells is that the studies that were most successful were performed on mutant rats or brains of deceased individuals. Such techniques are not only expensive, but their results might also vary from those performed on living human brains (due to anatomic and genetic differences). However, despite their limitations, studies on mutant mice have shown positive results. Researchers are thus hopeful that further research involving animals might lead to the development of a new therapy for ASD.
In the academic field there is also hope that new brain imaging techniques will bring new possibilities to research on the neurological basis of autism. Unfortunately, so far only a very limited number of Purkinje cell studies have focused on brain imaging techniques. Undoubtedly, more in vivo studies are needed because new brain scanning techniques seem to be useful in the future in the search for abnormalities in the brain area. Those shown by the Jeong research group (Jeong et al. 2014 ) have satisfactory results in linking Purkinje cells with ASD, and they involve the brains of living human ASD patients. Further research might be focused on other brain regions as well, to compare previous results. Furthermore, it is a better understanding of the role of each of the cerebellar regions is needed. The aim of future research will undoubtedly be the further study of the relationship between cerebellar impairment and autism spectrum disorder.
Conclusions
In the human brain there are different types of neurons that have different characteristics, and they respond differently to intoxication or injury. Purkinje cells in the cerebellum have been documented to play an important role; however, they are highly vulnerable to any type of insult. Unfortunately, the mechanisms that produce Purkinje neuron loss in autism remain unknown. What is known is that their abnormal functioning is closely linked with autism spectrum disorder symptomatology. Autism (both adult and infantile) is a behaviourally-defined condition associated with disrupted social interaction, communication, and specific behaviours.
All the studies discussed above (mutant mice models, post-mortem examinations, and in vivo neuroimaging methods) have confirmed the presupposition that Purkinje cells and autism are linked. There is hope in the implementation of brain imaging methods. Unfortunately, due to them being expensive, at this point only a very limited number of studies have tried to implement this technique.
Despite the consistency of findings suggesting that Purkinje cell loss and autism might have a common aetiology, more research is needed to investigate this statement. In addition, several researchers have suggested that the complexity of autism spectrum disorder might suggest that there are several coexisting causes of the disorder.
